Treatment of Pneumonia in Pregnancy
For mild community-acquired pneumonia in pregnant women managed as outpatients, oral amoxicillin is the first-line antibiotic for 7 days; for severe pneumonia requiring hospitalization, intravenous combination therapy with a β-lactam (co-amoxiclav, cefuroxime, or ceftriaxone) plus azithromycin is recommended. 1
Outpatient Management (Mild Pneumonia)
- Oral amoxicillin is the preferred first-line agent targeting Streptococcus pneumoniae, the most common bacterial pathogen in pregnancy-associated pneumonia 1
- Treatment duration should be 7 days for uncomplicated cases 1, 2
- Beta-lactam antibiotics (penicillins and cephalosporins) have not been associated with teratogenicity or increased toxicity and are safe throughout all trimesters 1
Inpatient Management (Severe Pneumonia)
- Immediate intravenous combination therapy is essential for hospitalized pregnant patients with severe pneumonia 1
- The preferred regimen consists of:
- Azithromycin is safer than clarithromycin, which should be avoided due to increased risk of birth defects and spontaneous abortion 1
- Treatment duration for severe pneumonia should be 10 days, or 14-21 days if legionella, staphylococcal, or gram-negative enteric bacilli are suspected 1
Transition from IV to Oral Therapy
- Switch to oral antibiotics when clinical improvement is evident, temperature has been normal for 24 hours, and no contraindications to oral administration exist 1, 2
- This transition should be reviewed daily to minimize unnecessary parenteral therapy 2
Management of Treatment Failure
If the patient fails to improve after 48-72 hours of therapy, conduct the following 1:
- Perform thorough clinical review with repeat chest radiograph, inflammatory markers, and further microbiological testing 1
- For non-severe pneumonia initially treated with amoxicillin monotherapy, add or substitute a macrolide 1
- For severe pneumonia not responding to combination therapy, consider adding rifampicin 1
Antibiotics to Avoid in Pregnancy
- Doxycycline is contraindicated due to increased hepatotoxicity and staining of fetal teeth and bones 1
- Clarithromycin should be avoided as first-line therapy due to teratogenic concerns 1
- Fluoroquinolones should generally be avoided unless benefits outweigh risks, though approximately 400 human pregnancy exposures have shown no increased birth defects 1
- Tetracyclines should not be administered after the fifth week of pregnancy and are deemed contraindicated 3
Special Pathogen Considerations
- For atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae), azithromycin is preferred over doxycycline 2, 1
- Amphotericin B is the treatment of choice when antifungal therapy is needed, as fluconazole and other azole antifungals are teratogenic 1
- For Legionella species, fluoroquinolones (levofloxacin or moxifloxacin) are preferred, though pregnancy-specific risks must be weighed 2
Critical Pregnancy-Specific Monitoring
- Pregnant women with pneumonia after 20 weeks of gestation should be monitored for contractions, as rates of preterm labor and preterm delivery are significantly increased 1
- Anemia and preeclampsia are associated with increased severity of pneumonia in pregnancy 4
- Chest radiographs should be obtained promptly when pneumonia is suspected to facilitate early diagnosis 4
Vaccination Considerations
- Inactivated influenza vaccine is recommended for all pregnant women who will be pregnant during influenza season to prevent severe viral pneumonia 1
- Live attenuated influenza vaccine should not be used during pregnancy 1
- Pneumococcal vaccination is not routinely recommended during pregnancy, though it can be administered safely if indicated 1, 2
Common Pitfalls
- Avoid delaying antibiotic administration, as prompt treatment is essential to reduce maternal and fetal complications including respiratory failure, low birth weight, and preterm birth 1, 5
- Do not underestimate severity in late pregnancy—delayed diagnoses are common and maternal mortality can reach 17% in severe cases 4
- Termination of pregnancy is recommended for patients in their third trimester when respiratory function deteriorates progressively, though continuation may be reasonable in first or second trimester 4